ArticleInfectious diseases and therapy2015

Dalbavancin: A Novel Lipoglycopeptide Antibiotic with Extended Activity Against Gram-Positive Infections.

Jordan R Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.